Home LiteratureArticle Details
PMID: 1388847 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Review

New carriers and adjuvants in the development of vaccines.

Current opinion in immunology ·Vol. 4 ·No. 4 ·1992-08-00 ·Pages 454-9

Del Giudice G

Abstract

Different approaches are being followed to enhance the immunogenicity of established and newly developed vaccines. Some of them foresee the utilization of carrier molecules recognized by the immune systems of a large proportion of the human population. Others are directed mainly towards the development of improved adjuvants and delivery systems.

MeSH Terms
Adjuvants, Immunologic Animals Antibody Formation Antigen-Presenting Cells/immunology Carrier Proteins/immunology Mice Mice, Inbred BALB C T-Lymphocytes, Helper-Inducer/immunology Vaccines/immunology
Chemicals
Adjuvants, Immunologic Carrier Proteins Vaccines
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Del Giudice G
World Health Organization, University of Geneva, Switzerland.
Article Info
Journal
Current opinion in immunology
Abbr.
Curr Opin Immunol
ISSN
0952-7915
DOI
10.1016/s0952-7915(06)80038-5
Published
1992-08-00
Pages
454-9
Language
English
Region
England
NLM ID
8900118
Subset
IM
External Links
PubMed source DOI: 10.1016/s0952-7915(06)80038-5 View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2